Caryn Cramer
About Caryn Cramer
Current Role as Vice President, Clinical Affairs & Epidemiology
Caryn Cramer currently holds the position of Vice President, Clinical Affairs & Epidemiology. In this role, she oversees clinical research and epidemiological studies. Her responsibilities include designing research protocols, managing studies, and analyzing data to support clinical and regulatory decision-making processes. Her leadership in this capacity plays a critical role in advancing the scientific understanding and practical applications of clinical and epidemiological findings.
Educational Background in Epidemiology and Environmental Studies
Caryn Cramer holds a PhD in Epidemiology and a Master of Science in Environmental Studies/Toxicology from the University of Michigan. Her advanced education in epidemiology underscores her expertise in studying the distribution and determinants of health-related states and events in specific populations. The combination of epidemiology and environmental toxicology provides her with a comprehensive understanding of how environmental factors influence public health.
Research on Dementia and Statins at the University of Michigan
Caryn Cramer has contributed to research on dementia and the use of statins at the University of Michigan. Her work in this study involved analyzing the effects of statins on cognitive health, thus expanding the scientific community's knowledge on potential treatments or preventatives for dementia. This research aligns with her background in epidemiology, emphasizing the relationship between pharmaceutical interventions and population health outcomes.
Previous Role as Director at Genzyme
Prior to her current role, Caryn Cramer served as the Director of Transplant & Oncology Scientific Reporting at Genzyme. In this position, she was responsible for overseeing scientific reporting and data analysis related to transplant and oncology treatments. Her role involved ensuring accurate and comprehensive reporting of clinical research findings to support product development and regulatory submissions.
Experience at Pfizer
Caryn Cramer has an extensive background at Pfizer, where she worked for nine years. She served as Director within the Regulatory Submissions group, focusing on the preparation and submission of regulatory documents required for drug approval and marketing. Her tenure at Pfizer provided her with in-depth knowledge of regulatory frameworks and processes, contributing significantly to her expertise in clinical and regulatory affairs.